SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

Where will US markets find their bottom? A model points to a potential 11% drop

Matrix looks to Wall Street: $2.1 billion merger could pave way for Nasdaq listing

IAI reports record $6.1 billion in sales as global demand for weapons surges

Buzz

Most popular

Daily

Weekly

1

Rapyd raises $500M at $4.5B valuation to complete $610M PayU acquisition

2

"Eventually, AI will surpass us in everything"—so what skills will still matter?

3

Cyber unicorn Pentera raises $60M at over $1B valuation as ARR approaches $100M

4

QuamCore raises $9 million in Seed funding to build scalable 1 million qubit quantum computer

5

Sola Security aims to be the Wix of cyber with $30 million Seed round

Urology

5 stories about Urology

Avner Geva Avi Eftel Vensica

Vensica Therapeutics raises $16 million for its urology treatment platform

01.11.21|James Spiro

The biopharma company’s needle-free platform can improve patient experience, resolve needle-related issues, and make procedures easier

מנכ"ל מדיטייט עידו קילמניק עם ונסה מלכה סמנכ"לית מדיטייט

Israel’s Medi-Tate acquired by Japanese powerhouse Olympus Corporation for $300 million

26.02.21|Meir Orbach

The Israeli manufacturer of non-surgical solutions for BPH had previously raised $37 million from private investors

Johnson & Johnson Subsidiary Janssen Partners With Sustained Drug Release Company UroGen

The two companies will collaborate on the research of a “therapeutic area of mutual interest”

Sustained Drug Release Company UroGen Aiming to Raise $150 Million on Nasdaq

24.01.19|Lilach Baumer

Goldman Sachs & Co. LLC, JP Morgan, and Jefferies are the joint bookrunners for the offering

Vensica Medical Device

Overactive Bladder Treatment Startup Raises $2 Million

01.10.17|Lilach Baumer

Israel-based Vensica Medical developed an ultrasound-based device for needle-free delivery of Botox to the bladder